MENU
+Compare
OVID
Stock ticker: NASDAQ
AS OF
Apr 2 closing price
Price
$0.34
Change
+$0.03 (+9.68%)
Capitalization
24.17M

OVID Ovid Therapeutics Forecast, Technical & Fundamental Analysis

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OVID with price predictions
Apr 02, 2025

OVID in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 27, 2025

OVID may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where OVID's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OVID's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OVID advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for OVID turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OVID declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OVID entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.354) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (42.553) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OVID’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OVID’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OVID is expected to report earnings to rise 10.23% to -14 cents per share on May 08

Ovid Therapeutics OVID Stock Earnings Reports
Q1'25
Est.
$-0.14
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.34
Q1'24
Beat
by $0.05
The last earnings report on March 11 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 168.19K shares outstanding, the current market capitalization sits at 24.17M.
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VHC8.440.34
+4.20%
VirnetX Holding Corp
CRCT5.330.11
+2.11%
Cricut
RUSHB59.521.04
+1.78%
Rush Enterprises
HIG124.860.47
+0.38%
The Hartford Insurance Group Inc.
NREF14.91-0.02
-0.13%
NexPoint Real Estate Finance

OVID and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with AVTE. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then AVTE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+9.78%
AVTE - OVID
90%
Closely correlated
+0.40%
SYRE - OVID
45%
Loosely correlated
+1.27%
NAUT - OVID
36%
Loosely correlated
+7.47%
TVTX - OVID
36%
Loosely correlated
+2.87%
NRIX - OVID
36%
Loosely correlated
+8.69%
More

Groups containing OVID

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+9.78%
OVID
(2 stocks)
92%
Closely correlated
+5.09%